Home Daiichi-Sankyo

Daiichi-Sankyo

acquired
IPO
Pharmaceutical R&D Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Daiichi Sankyo Company, Limited. is a multinational pharmaceutical company with origins in Japan. We provide innovative products and services in over 20 countries and regions worldwide. With years of scientific expertise, our company leverages a rich tradition of innovation and a robust pipeline of promising new drugs to help patients. Through the exceptional knowledge and commitment of our 15,000 employees globally, we create innovative new drugs and generics, as well as novel approaches to drug discovery and delivery. We are passionate about innovation and empathetic towards patients around the world who need our medicines.
Daiichi Sankyo Company Limited
Tokyo,Tokyo,Japan
more than 500 people
September 28, 2005
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products Immune Cell Therapy
Technology
Gene Technology Immunological Techniques Cell Technology
Concept
Physical Examination Diagnosis Ovarian Cancer Breast Cancer Lung Cancer Gastric Cancer Lymphoma Leukemia Lupus Erythematosus
Application Scenarios
Innovative Drugs Prescription Drug Over-the-Counter Drugs ADC (Antibody-Drug Conjugate) Nucleic Acid Drugs Cell and Gene Therapy